Zerion Pharma A/S: Financial statements 2020
CVR: 40169229
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Zerion Pharma A/S (CVR 40169229) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 784,282 and a net result of DKK -3,477,649 compared with DKK -1,050,624 the year before. Equity in the 2020 report amounted to DKK -1,029,105. The company had 3 employees in the financial year.
- Gross Profit
- DKK 784,282
- Profit/Loss
- DKK -3,477,649
- Equity
- DKK -1,029,105
- Total Assets
- DKK 6,999,753
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 784 t. | -3.5 mio. | -1 mio. | 3 |
| 2019 | - | -1.1 mio. | -1.1 mio. | 31 t. | 3 |
Official annual report
How creditworthy is Zerion Pharma A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Zerion Pharma A/S has published its annual report for 2019. Gross profit came to DKK -1,068,242, and the net result was DKK -1,050,624.
As of April 27, 2020, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of Zerion Pharma A/S.
About Zerion Pharma A/S
Zerion Pharma A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Zerion Pharma ApS and Zerion ApS. The management consists of Ole Sylvester-Hvid Wiborg. The board consists of Carl-Åke Carlsson (chair), Geelanie Rodriguez Briones, Allan Stich and Dorte Juhl Arnbjerg. The company's owners include Geelanie Rodriguez Briones, WIBORG INTERNATIONAL HOLDING ApS and Waterman ApS. The company has 15 employees (2026). In 2025, the company reported revenue of DKK 3,377,646 and a net result of DKK -10,830,354 compared with DKK -220,020 the year before. Equity in the 2025 report amounted to DKK -3,511,410.